Rofecoxib administration to paediatric patients undergoing adenotonsillectomy

Paediatric Anaesthesia - Tập 14 Số 7 - Trang 579-583 - 2004
Paul Sheeran1, John B. Rose2, L Fazi2, Rosetta Chiavacci2, L. McCormick2
1Departments of Anesthesiology and Pediatrics, University of Texas Southwestern Medical Center, USA.
2Department of Anaesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA

Tóm tắt

SummaryBackground : Rofecoxib is a selective COX‐2 inhibitor that does not interfere with platelet function and is associated with fewer bleeding complications than other nonsteroidal anti‐inflammatory agents (NSAIDs). Our aims were to evaluate the safety and the efficacy of rofecoxib administration to paediatric patients undergoing adenotonsillectomy (T&A).Methods : We conducted a double‐blind, randomized, placebo‐controlled study of rofecoxib in 45 ASA 1–2 patients ≥4 years of age undergoing outpatient T&A. All patients received midazolam 0.5 mg·kg−1 (max 15 mg) p.o. and either rofecoxib 1 mg·kg−1 (max 25 mg) or placebo p.o. 30 min preoperatively. All patients had a standardized anaesthetic and were extubated awake in the operating room at the conclusion of surgery. The Children's Hospital of Eastern Ontario Pain Scale (CHEOPS) scores were obtained on arrival in the postanaesthetic care unit (PACU). Morphine 25 μg·kg−1 i.v. were administered up to six times for pain in the PACU. Wong–Baker FACES Scales were obtained at discharge from the PACU and the day surgery unit (DSU). Outcome measures included intraoperative estimated blood loss (EBL), pain scores, PACU morphine requirements and discharge times.Results : There were 23 patients in the rofecoxib group and 22 patients in the placebo group. There were no differences between the rofecoxib and placebo groups in terms of bleeding, pain scores, PACU morphine requirements, PACU times or DSU times.Conclusion : Rofecoxib administration to paediatric patients undergoing T&A did not result in increased bleeding. Rofecoxib, however, was not found to decrease morphine use or improve pain scores prior to hospital discharge in T&A patients who received intraoperative morphine and acetaminophen.

Từ khóa


Tài liệu tham khảo

10.1111/j.1365-2273.1996.tb01310.x

10.1016/S0194-5998(98)70376-6

10.1111/j.1399-6576.1998.tb05320.x

10.1016/0304-3959(94)00166-C

10.1097/00000539-199502000-00004

Fitz‐James I, 1995, Effect of ketorolac on peri‐operative bleeding and analgesia in pediatric tonsillectomy and adenoidectomy patients (abs), Anesth Analg, 80, S581

10.1007/BF03011766

10.1213/00000539-199512000-00004

10.1288/00005537-199506000-00008

10.1001/archotol.1996.01890210017004

10.2165/00003495-199958030-00016

10.1002/1529-0131(200002)43:2<370::AID-ANR17>3.0.CO;2-D

10.1001/jama.282.20.1929

Chan C‐C, 1999, Rofecoxib (Vioxx, MK‐0966; 4‐(4’Methylsulfonlyphenyl)‐ 3‐phenyl‐2‐(5H)‐furanone): a potent and orally active cyclooxgenase‐2 inhibitor. Pharmacological and biochemical profiles, J Pharm Exp Ther, 290, 551

10.1345/aph.18415

10.1097/00000539-200011000-00032

10.14219/jada.archive.2000.0119

10.1001/archinte.160.12.1781

10.1056/NEJM200011233432103

10.1016/S0029-7844(99)00360-9

10.1016/0304-3959(93)90163-J

Whaley L, 1991, Nursing Care of Infants and Children

10.1097/00000539-200101000-00011

10.1093/bja/88.1.72

10.1213/01.ANE.0000069507.93582.6E

10.1093/bja/85.2.224

10.1093/bja/78.1.24

10.1093/bja/81.6.870

Thông tin
Thông tin xuất bản

Paediatric Anaesthesia

Tập 14 Số 7

579-583

Thông tin tác giả